Researchers monitor Esmya's Long-Term safety in women with fibroids
Knowledge-focused
Completed
This study followed over 1,500 women with moderate to severe uterine fibroids who were taking Esmya long-term. Researchers tracked side effects, especially those affecting the uterus, and how doctors prescribed the drug in real-world practice. The goal was to better understand th…
Sponsor: PregLem SA • Aim: Knowledge-focused
Last updated May 12, 2026 13:43 UTC